Items Tagged ‘B-cell precursor acute lymphoblastic leukemia’

December 16th, 2015

Addition of Rituxan Improves Outcomes in Some Acute Lymphoblastic Leukemias

By

The addition of Rituxan (rituximab) to standard chemotherapy-based regimens improves outcomes among patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) that is CD20-positive. These results were reported at a plenary session at the 2015 annual meeting of the American Society of Hematology in Orlando, Florida. B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is an aggressive type […]

View full entry

Tags: Acute Lymphoblastic Leukemia, B-cell precursor acute lymphoblastic leukemia, BCP-ALL, CD20-positive, Leukemia, News, riruximab, rituxan